Transcept Pharmaceuticals, Inc.
Balance Sheets
March 31, December 31,
2009 2008
Assets (Unaudited)
Current assets:
Cash and cash equivalents $35,039,350 $4,431,505
Marketable securities 45,926,992 7,250,987
Prepaid and other current assets 1,878,460 381,836
Restricted cash 200,000 200,000
Total current assets 83,044,802 12,264,328
Property and equipment, net 1,457,536 1,450,216
Goodwill 2,961,664 -
Other assets 826,243 65,970
Total assets $88,290,245 $13,780,514
Liabilities, convertible preferred
stock and stockholders' equity (net
capital deficiency)
Current liabilities:
Accounts payable $1,314,743 $575,269
Accrued liabilities 3,098,358 1,468,415
Assumed lease liability,
short-term portion 233,568 -
Loan payable, short-term portion 42,139 3,347,010
Total current liabilities 4,688,808 5,390,694
Warrant liability - 599,845
Deposit for stock purchase 75,697 87,656
Deferred rent 82,695 77,044
Assumed lease liability,
long-term portion 583,919 -
Loan payab
'/>"/>
| SOURCE Transcept Pharmaceuticals, Inc. Copyright©2009 PR Newswire. All rights reserved |